pyruvic acid has been researched along with Cancer of Esophagus in 4 studies
Pyruvic Acid: An intermediate compound in the metabolism of carbohydrates, proteins, and fats. In thiamine deficiency, its oxidation is retarded and it accumulates in the tissues, especially in nervous structures. (From Stedman, 26th ed)
pyruvic acid : A 2-oxo monocarboxylic acid that is the 2-keto derivative of propionic acid. It is a metabolite obtained during glycolysis.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Critical ischemia was suspected in two cases." | 1.35 | Free jejunal flaps can be monitored by use of microdialysis. ( Sorensen, HB, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ye, W | 1 |
| Lin, Y | 1 |
| Bezabeh, T | 1 |
| Ma, C | 1 |
| Liang, J | 1 |
| Zhao, J | 1 |
| Ouyang, T | 1 |
| Tang, W | 1 |
| Wu, R | 1 |
| Li, Y | 1 |
| Li, X | 2 |
| Kan, Q | 1 |
| Zhang, M | 1 |
| Xu, R | 1 |
| Wang, J | 1 |
| Yu, D | 1 |
| Goscinski, MA | 1 |
| Wen, JG | 1 |
| Nesland, JM | 1 |
| Suo, Z | 1 |
| Sorensen, HB | 1 |
| Gorozhanskaia, EG | 1 |
| Gromova, EG | 1 |
| Sviridova, SP | 1 |
4 other studies available for pyruvic acid and Cancer of Esophagus
| Article | Year |
|---|---|
Topics: Adult; Aged; Biomarkers, Tumor; Case-Control Studies; Esophageal Neoplasms; Female; Gene Expression | 2021 |
Mitochondrial pyruvate carrier function is negatively linked to Warburg phenotype in vitro and malignant features in esophageal squamous cell carcinomas.
Topics: Adenosine Triphosphate; Biological Transport; Carcinoma, Squamous Cell; Cell Line, Tumor; Esophageal | 2017 |
Free jejunal flaps can be monitored by use of microdialysis.
Topics: Aged; Esophageal Neoplasms; Esophagoplasty; Esophagus; Female; Glucose; Humans; Ischemia; Jejunum; L | 2008 |
[The role of ascorbic acid in the combined preoperative preparation of cancer patients].
Topics: Administration, Oral; Ascorbic Acid; Ascorbic Acid Deficiency; Combined Modality Therapy; Esophageal | 1989 |